Savencia: cheaply paid…

Airbus: Deutsche Bank downgrades to Hold

AstraZeneca: protocol around Tagrisso approved in Japan

Market: No new element to extend the increase

AstraZeneca: inconclusive trial for Infinzi in NSCL